Biogen Hemophilia Inc. – Trademark Portfolio
Entity Type: 03
Biogen Hemophilia Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. Currently, 1 trademark is registered. Notable registered marks include BIOVERATIV. The owner is based in Cambridge, MA.
250 Binney Street
Cambridge, MA 02142
Showing of trademarks Trademarks
Trademark Classifications
Biogen Hemophilia Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Biogen Hemophilia Inc. have?
Biogen Hemophilia Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.
What trademark classes does Biogen Hemophilia Inc. file in?
Biogen Hemophilia Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Biogen Hemophilia Inc.'s most well-known trademarks?
Biogen Hemophilia Inc.'s registered trademark portfolio includes well-known marks such as BIOVERATIV. These are among 1 currently registered trademark in the portfolio.
What is Biogen Hemophilia Inc.'s trademark registration success rate?
Biogen Hemophilia Inc. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.